Close Menu

NEW YORK — PredictImmune said on Tuesday that it has signed an agreement for promotion and distribution of its PredictSure IBD test in the UK, Ireland, the Middle East, and the Balkans with Cambridge Clinical Laboratories (CCL).

PredictSure IBD is a PCR-based test is designed to analyze the expression of 17 genes in whole blood in order to differentiate mild and aggressive forms of Crohn's disease and ulcerative colitis and to guide treatment options.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.